Oberon Investments - Total Voting Rights
RNS Number : 4088Q
Oberon Investments Group PLC
26 February 2021


Baskerville Capital plc

('Baskerville', the 'Group' or the 'Company')

(To be renamed Oberon Investments Group plc)

('Oberon' or 'Oberon Investments')


Total Voting Rights


In accordance with the FCA's Disclosure Guidance and Transparency Rules, as at 26 February 2021, the Company's issued share capital consists of 407,789,775 Ordinary Shares of 0.5p, each with one voting right. The Company does not hold any Ordinary Shares in treasury. Therefore, the total number of voting rights in the Company is 407,789,775.

The above figure of 407,789,775 should be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

The directors of Baskerville Capital plc accept responsibility for this announcement.




Baskerville Capital plc


Simon McGivern / John Beaumont


via Walbrook PR

AQSE Corporate Adviser and Broker


Novum Securities Limited


Richard Potts / Daphne Zhang / Lucy Bowden

020 7399 9400



Walbrook PR Ltd

Tom Cooper / Nick Rome

Tel: 020 7933 8780 or Oberon@walbrookpr.com




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.